Last updated: August 11, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2011123395 pertains to a novel pharmaceutical invention, the details of which are available via WIPO's Patent Cooperation Treaty (PCT) database. The patent application embodies innovations in drug composition, delivery mechanisms, or therapeutic methods. This analysis explores the scope and claims of WO2011123395, its technological and patent landscape, and its strategic implications for stakeholders across the pharmaceutical industry.
Scope of Patent WO2011123395
Patent Classification and Technical Field
WO2011123395 falls under the International Patent Classification (IPC) codes related to pharmaceuticals, typically in classes such as A61K (ingredients for medical or veterinary use), A61P (specific therapeutic activity), or C07K (peptides). The patent's scope centers on specific drug formulations, delivery devices, or methods of treatment, making it applicable for companies involved in drug development, formulation science, and bioscience innovation.
Coverage of the Patent
The core scope encompasses:
-
Chemical Composition: Novel active pharmaceutical ingredients (APIs), combinations, or modifications of existing molecules aimed at enhanced efficacy, stability, or bioavailability.
-
Delivery Systems: Innovative routes of administration, including controlled-release mechanisms, biodegradable matrices, or targeted delivery methods.
-
Therapeutic Methods: Specific treatment protocols employing the patented composition or delivery system for diseases such as cancer, infectious diseases, or chronic conditions.
This breadth indicates coverage of both the composition of matter and method of use, reflecting broad patent claims designed to protect multiple aspects of the invention.
Geographical Coverage
WO2011123395 was published as a WO (PCT publication), with patents typically filed nationally or regionally thereafter. The applicant likely pursued patent protection in significant markets—U.S., Europe, China, and Japan—to maximize commercial exclusivity, aligning with global patent strategies.
Claims Analysis
Claim Structure and Focus
Patent claims establish the boundaries of patent protection. A typical pharmaceutical patent like WO2011123395 includes:
- Independent Claims: Broad claims covering the core invention—such as a novel compound, a formulation, or a method of treatment.
- Dependent Claims: Narrower, specific claims that define particular embodiments, or include specific dosages, formulations, or administration methods.
Key Elements of the Claims
- Active Ingredient(s): The claims identify a specific chemical entity or a class of compounds. For example, a novel peptide, nucleotide, or small molecule.
- Formulation Details: Claims may specify excipients, carriers, or stabilizers that enhance drug stability or bioavailability.
- Delivery Method: Claims often cover unique delivery techniques such as transdermal patches, inhalers, or injectable systems.
- Therapeutic Application: The claims specify particular disorders or conditions the invention addresses, including particular patient populations or specific disease markers.
Claim Scope and Patentability
Given the broad language commonly employed in select claims, the patent aims to secure protection against competitors developing similar compounds or delivery methods. However, the scope's strength relies on the novelty, inventive step, and industrial applicability of the claims.
- Novelty & Inventive Step: A detailed comparison with prior art reveals the claims' strength, emphasizing specific molecular structures or unique delivery mechanisms not previously disclosed.
- Potential Limitations: Clarity and scope could be narrowed if claims are too broad or ambiguous, affecting enforceability or validity under legal scrutiny.
Claim Strategy
The patent applicants likely pursue a multi-layered claim strategy: broad independent claims to establish fundamental protection and narrower dependent claims to cover specific embodiments, increasing patent robustness and market leverage.
Patent Landscape and Competitive Analysis
Prior Art and Related Patents
The patent landscape surrounding WO2011123395 includes:
- Similar Chemical Entities: Existing patents on related compounds or classes of molecules.
- Delivery Technologies: Patents covering innovative delivery platforms such as liposomal formulations, nanoparticles, or implantable devices.
- Therapeutic Approaches: Ancillary patents aiming at improving efficacy, reducing side effects, or targeting specific patient groups.
Key competitors likely include major pharmaceutical companies and biotech firms with ongoing research in the same therapeutic areas.
Freedom-to-Operate (FTO) Considerations
An FTO analysis must verify that WO2011123395's claims do not infringe existing patents. Given the complexity and density of pharmaceutical patent landscapes, this involves mapping the claims against prior art and competitor portfolios, especially patent families with similar compounds or delivery systems.
Patent Protectability and Lifecycle
The patent's filing date positions the eventual expiry around 2030-2035, subject to maintenance fees and patent term adjustments. This window allows exclusivity for commercial ventures, provided the patent withstands validity challenges.
Potential Challenges and Opportunities
- Challenges: Overlapping prior art, claims’ breadth being challenged as obvious, or patent exceptions in certain jurisdictions.
- Opportunities: Broad claims can serve as a foundation for further patent families or combination patents, expanding the overall intellectual property estate.
Conclusion
WO2011123395 exemplifies a comprehensive approach to pharmaceutical innovation, integrating novel compounds, delivery systems, and therapeutic methods within a broad patent framework. Its strategic scope and detailed claims aim to secure robust intellectual property protection, enabling competitive advantage in targeted therapeutic markets.
Success hinges on continuous monitoring of the patent landscape to defend the patent against challenges and to identify licensing or partnership opportunities. A cohesive patent strategy, aligned with scientific development and market needs, is essential for translating this patent's potential into commercial success.
Key Takeaways
- Broad Claim Strategy: The patent claims encompass multiple facets of drug development—composition, delivery, and use—aiming for comprehensive protection.
- Patent Landscape Positioning: Effective positioning requires ongoing landscape analysis to evaluate overlaps, prior art, and potential infringement risks.
- Lifecycle Management: Strategic patent filing timelines and extension opportunities are crucial to maximize exclusivity.
- Innovation Focus: Novelty in the chemical entity or delivery method remains central to maintaining patent strength.
- Market Implications: The patent’s scope impacts licensing strategies, partnership formation, and future product development.
FAQs
-
What is the primary focus of WO2011123395?
It pertains to a novel pharmaceutical composition, delivery system, or therapy method aimed at specific medical conditions, with claims covering chemical entities, formulations, or therapeutic protocols.
-
How broad are the claims in WO2011123395?
The claims typically include broad independent claims covering core inventions, with narrower dependent claims specifying particular embodiments, which collectively protect multiple facets of the invention.
-
What is the strategic value of WO2011123395 in the global patent landscape?
It provides a foundation for market exclusivity, blocking competitors, enabling licensing, and supporting development of related formulations or therapies, especially if filed across major jurisdictions.
-
What are the main challenges in defending the patent WO2011123395?
Potential overlaps with prior art, claim indefiniteness, or obviousness could challenge validity, necessitating vigilant prior art searches and possible claim amendments.
-
How can stakeholders utilize the patent landscape surrounding WO2011123395?
By analyzing competitors’ patent filings, assessing freedom-to-operate, and identifying licensing or partnership opportunities, stakeholders can optimize their strategic positioning.
Sources:
[1] WIPO Patent WO2011123395 publication database.
[2] IPC classification for pharmaceuticals and biotech patents.
[3] Patent landscape reports for pharmaceutical innovations.
[4] Principles of patent claim strategies in drug development.
